NIPH Clinical Trials Search

Development of a cervical cancer recurrence monitoring test

Basic Information

Recruitment status	Recruiting
Health condition(s) or Problem(s) studied	Locally advanced cervical cancer
Date of first enrollment	07/05/2026
Target sample size	30
Countries of recruitment
Study type	Observational
Intervention(s)

Outcome(s)

Primary Outcome	Tumor marker identification rate Detection rate of tumor markers
Secondary Outcome	Efficiency and quality of tumor marker candidate extraction from blood Accuracy of tumor marker identification methods and detectable HPV types Change in tumor markers in blood

Key inclusion & exclusion criteria

Age minimum	>= 20age old
Age maximum	Not applicable
Gender	Female
Include criteria	1) Age => 20 years. 2) Patients who have received a sufficient explanation of the study and have provided written informed consent based on their own free will. 3) Patients diagnosed with HPV-associated cervical cancer with a clinical stage of IB2 or higher. 4) Patients scheduled to undergo curative surgery or definitive concurrent chemoradiotherapy (CCRT).
Exclude criteria	1) Patients who are judged to be inappropriate for participation in the study by the principal investigator or sub-investigator.